Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

William Bradshaw

Physician Assistant Glasgow, KY Physician Assistant

NPI 1760076657 CMS profile 11254485

211 Professional Park Dr, Glasgow, KY 42141

Open in the dashboard

General payments

$4,956

315 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Bradshaw of Glasgow, KY is reported in the CMS Open Payments database as having received $4,956 across 315 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,080 62
2024 General $867 50
2023 General $1,116 72
2022 General $1,490 104
2021 General $403 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Bradshaw
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to William Bradshaw were reported at $1,080. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year William Bradshaw Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $403 $132 $37–$438 $132
2022 $1,490 $155 $48–$522 $149
2023 $1,116 $167 $52–$557 $160
2024 $867 $178 $55–$600 $164
2025 $1,080 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novartis Pharmaceuticals Corporation $787 60 payments
  2. Bayer HealthCare Pharmaceuticals Inc. $578 37 payments
  3. AstraZeneca Pharmaceuticals LP $530 21 payments
  4. Novo Nordisk Inc $523 39 payments
  5. AbbVie, Inc. $270 15 payments
  6. Axsome Therapeutics, Inc. $251 15 payments
  7. GlaxoSmithKline, LLC. $209 12 payments
  8. Mylan Specialty L.P. $194 14 payments
  9. Lilly USA, LLC $184 12 payments
  10. Kowa Pharmaceuticals America, Inc. $181 13 payments
  11. Other $1,248 77 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,936 314 payments
  2. Education $20 1 payment
Products named General payments · program years 2021–2025
  1. LEQVIO $630 49 payments
  2. Kerendia $578 37 payments
  3. ENTRESTO $501 36 payments
  4. FARXIGA $375 10 payments
  5. AIRSUPRA $275 4 payments
  6. RYBELSUS $256 18 payments
  7. Auvelity $251 15 payments
  8. Ozempic $238 17 payments
  9. YUPELRI $231 16 payments
  10. TRELEGY ELLIPTA $209 12 payments
  11. Other $3,014 186 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

315 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record